Benzodiazepine intervention in adults receiving opioid agonist treatment

Key information made simple

This study is testing a medication approach for people with Medical condition: enrolled in OAT with DSM-5-diagnosed substance use disorder with toxicologically verified non-prescription benzodiazepine use in the previous month. Medical condition in lay language: who are enrolled in Opioid Agonist Treatment programme who are using non-prescribed benzodiazepine. Therapeutic areas: Psychiatry and Psychology [F] - Behaviours [F01] or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments. Direct benefit is not guaranteed, but the study may help researchers improve future care.

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.